OC-0611 HDR brachytherapy boost improves metastatic free survival in high and very-high risk prostate cancer. (May 2022) - Visus, I.; Barco, A.; Obeso, J.; Barrado, M.; Sola, A.; Villafranca, E.; Fuentemilla, N.; Pellejero, S.; Navarrete, P.; Martinez, E.